Confluent (CFLT) 10-Q 31 Jul 24 2024 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jun. 30, 2024	Jul. 24, 2024
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Trading Symbol	CFLT
Entity Registrant Name	CONFLUENT, INC.
Entity Central Index Key	0001699838
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Shell Company	false
Title of 12(b) Security	Class A Common Stock, par value $0.00001 per share
Entity File Number	001-40526
Security Exchange Name	NASDAQ
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-1824387
Entity Address, Address Line One	899 W. Evelyn Avenue
Entity Address, City or Town	Mountain View
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94041
City Area Code	800
Local Phone Number	439-3207
Document Transition Report	false
Document Quarterly Report	true
Class B Common Stock [Member]
Entity Common Stock, Shares Outstanding		72,654,851
Class A Common Stock [Member]
Entity Common Stock, Shares Outstanding		250,068,648

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 311,328	$ 349,761
Marketable securities	1,619,853	1,551,009
Accounts receivable, net	257,485	229,962
Deferred contract acquisition costs	44,433	43,937
Prepaid expenses and other current assets	74,135	76,986
Total current assets	2,307,234	2,251,655
Property and equipment, net	66,791	54,012
Operating lease right-of-use assets	9,997	10,061
Goodwill and intangible assets, net	54,487	55,490
Deferred contract acquisition costs, non-current	74,251	75,815
Other assets, non-current	15,706	13,776
Total assets	2,528,466	2,460,809
Current liabilities:
Accounts payable	13,990	6,714
Accrued expenses and other liabilities	166,777	141,847
Operating lease liabilities	10,574	7,890
Deferred revenue	328,845	330,570
Total current liabilities	520,186	487,021
Operating lease liabilities, non-current	12,566	17,391
Deferred revenue, non-current	19,608	22,436
Convertible senior notes, net	1,090,219	1,088,313
Other liabilities, non-current	12,023	35,233
Total liabilities	1,654,602	1,650,394
Commitments and contingencies (Note 9)
Stockholders' equity:
Preferred stock, par value of $0.00001 per share; 10,000,000 shares authorized as of June 30, 2024 and December 31, 2023; 0 shares issued and outstanding as of June 30, 2024 and December 31, 2023	0	0
Additional paid-in capital	2,702,980	2,453,293
Accumulated other comprehensive (loss) income	(2,101)	1,270
Accumulated deficit	(1,827,018)	(1,644,151)
Total stockholders' equity	873,864	810,415
Total liabilities and stockholders' equity	2,528,466	2,460,809
Class A Common Stock [Member]
Stockholders' equity:
Common Stock, Value	2	2
Class B Common Stock [Member]
Stockholders' equity:
Common Stock, Value	$ 1	$ 1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Preferred Stock, Par Value	$ 0.00001	$ 0.00001
Preferred Stock, Shares Authorized	10,000,000	10,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Class A Common Stock [Member]
Common Stock, Par Value	$ 0.00001	$ 0.00001
Common Stock, Shares Authorized	1,000,000,000	1,000,000,000
Common Stock, Shares, Issued	249,550,761	224,737,415
Common Stock, Shares, Outstanding	249,550,761	224,737,415
Class B Common Stock [Member]
Common Stock, Par Value	$ 0.00001	$ 0.00001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	72,682,140	86,774,127
Common Stock, Shares, Outstanding	72,682,140	86,774,127

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenue:
Total revenue	$ 234,986	$ 189,285	$ 452,223	$ 363,587
Cost of revenue:
Total cost of revenue	64,981	57,920	126,202	116,064
Gross profit	170,005	131,365	326,021	247,523
Operating expenses:
Research and development	106,060	85,677	203,631	170,567
Sales and marketing	132,865	127,770	264,217	256,394
General and administrative	39,429	36,343	77,873	71,698
Restructuring and other related charges	0	943	0	34,325
Total operating expenses	278,354	250,733	545,721	532,984
Operating loss	(108,349)	(119,368)	(219,700)	(285,461)
Other income, net	21,853	17,610	42,703	32,795
Loss before income taxes	(86,496)	(101,758)	(176,997)	(252,666)
Provision for income taxes	3,404	1,667	5,870	3,314
Net loss	$ (89,900)	$ (103,425)	$ (182,867)	$ (255,980)
Net loss per share, basic	$ (0.28)	$ (0.35)	$ (0.58)	$ (0.87)
Net loss per share, diluted	$ (0.28)	$ (0.35)	$ (0.58)	$ (0.87)
Weighted-average shares used to compute net loss per share, basic	319,415,586	297,827,200	316,809,384	294,862,197
Weighted-average shares used to compute net loss per share, diluted	319,415,586	297,827,200	316,809,384	294,862,197
Subscription [Member]
Revenue:
Total revenue	$ 224,702	$ 176,488	$ 431,604	$ 337,055
Cost of revenue:
Total cost of revenue	52,863	44,188	101,218	87,093
Services [Member]
Revenue:
Total revenue	10,284	12,797	20,619	26,532
Cost of revenue:
Total cost of revenue	$ 12,118	$ 13,732	$ 24,984	$ 28,971

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Net loss	$ (89,900)	$ (103,425)	$ (182,867)	$ (255,980)
Other comprehensive income (loss), net of tax:
Net unrealized loss on marketable securities	(274)	(5,574)	(2,140)	(1,415)
Net unrealized gain (loss) on derivative instruments	506	222	(1,231)	1,065
Other comprehensive income (loss), net of tax	232	(5,352)	(3,371)	(350)
Total comprehensive loss	$ (89,668)	$ (108,777)	$ (186,238)	$ (256,330)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders Equity (Unaudited) - USD ($) $ in Thousands	Total	Class A and Class B [Member]	Additional Paid-In Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Balance at Dec. 31, 2022	$ 769,477	$ 3	$ 1,980,335	$ (9,456)	$ (1,201,405)
Balance (shares) at Dec. 31, 2022		289,384,180
Repurchases of unvested common stock (shares)		(30,828)
Vesting of early exercised options	1,904		1,904
Issuance of common stock upon exercise of vested options	47,983		47,983
Issuance of common stock upon exercise of vested options (shares)		7,241,647
Vesting of restricted stock units (shares)		4,368,636
Issuance of common stock under employee stock purchase plan	17,172		17,172
Issuance of common stock under employee stock purchase plan (shares)		714,586
Stock-based compensation	181,180		181,180
Other comprehensive income (loss), net of tax	(350)			(350)
Net Income (Loss)	(255,980)				(255,980)
Balance at Jun. 30, 2023	761,386	$ 3	2,228,574	(9,806)	(1,457,385)
Balance (shares) at Jun. 30, 2023		301,678,221
Balance at Mar. 31, 2023	744,851	$ 3	2,103,262	(4,454)	(1,353,960)
Balance (shares) at Mar. 31, 2023		295,378,610
Vesting of early exercised options	629		629
Issuance of common stock upon exercise of vested options	26,714		26,714
Issuance of common stock upon exercise of vested options (shares)		3,645,882
Vesting of restricted stock units (shares)		2,653,729
Stock-based compensation	97,969		97,969
Other comprehensive income (loss), net of tax	(5,352)			(5,352)
Net Income (Loss)	(103,425)				(103,425)
Balance at Jun. 30, 2023	761,386	$ 3	2,228,574	(9,806)	(1,457,385)
Balance (shares) at Jun. 30, 2023		301,678,221
Balance at Dec. 31, 2023	810,415	$ 3	2,453,293	1,270	(1,644,151)
Balance (shares) at Dec. 31, 2023		311,511,542
Vesting of early exercised options	617		617
Issuance of common stock upon exercise of vested options	$ 28,936		28,936
Issuance of common stock upon exercise of vested options (shares)	3,947,036	3,947,036
Vesting of restricted stock units (shares)		6,100,168
Issuance of common stock under employee stock purchase plan	$ 15,603		15,603
Issuance of common stock under employee stock purchase plan (shares)		674,155
Stock-based compensation	204,531		204,531
Other comprehensive income (loss), net of tax	(3,371)			(3,371)
Net Income (Loss)	(182,867)				(182,867)
Balance at Jun. 30, 2024	873,864	$ 3	2,702,980	(2,101)	(1,827,018)
Balance (shares) at Jun. 30, 2024		322,232,901
Balance at Mar. 31, 2024	845,217	$ 3	2,584,665	(2,333)	(1,737,118)
Balance (shares) at Mar. 31, 2024		317,262,580
Vesting of early exercised options	301		301
Issuance of common stock upon exercise of vested options	14,402		14,402
Issuance of common stock upon exercise of vested options (shares)		1,689,204
Vesting of restricted stock units (shares)		3,281,117
Stock-based compensation	103,612		103,612
Other comprehensive income (loss), net of tax	232			232
Net Income (Loss)	(89,900)				(89,900)
Balance at Jun. 30, 2024	$ 873,864	$ 3	$ 2,702,980	$ (2,101)	$ (1,827,018)
Balance (shares) at Jun. 30, 2024		322,232,901

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income (Loss)	$ (182,867)	$ (255,980)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	10,153	6,378
Net accretion of discounts on marketable securities	(20,267)	(19,721)
Amortization of debt issuance costs	1,906	1,889
Amortization of deferred contract acquisition costs	26,096	21,537
Non-cash operating lease costs	1,854	2,184
Lease abandonment charges	0	15,667
Stock-based compensation, net of amounts capitalized	194,429	171,448
Deferred income taxes	342	10
Other	1,210	851
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	(28,658)	(11,293)
Deferred contract acquisition costs	(25,028)	(23,966)
Prepaid expenses and other assets	1,774	(6,057)
Accounts payable	7,055	(18,720)
Accrued expenses and other liabilities	3,141	7,552
Operating lease liabilities	(3,929)	(3,754)
Deferred revenue	(4,575)	5,143
Net cash used in operating activities	(17,364)	(106,832)
CASH FLOWS FROM INVESTING ACTIVITIES
Capitalization of internal-use software costs	(10,315)	(9,886)
Purchases of marketable securities	(899,190)	(999,764)
Sales of marketable securities	12,744	0
Maturities of marketable securities	835,756	975,383
Purchases of investments in privately-held companies	(1,000)	0
Purchases of property and equipment	(1,291)	(1,355)
Cash paid for business combinations, net of cash acquired	0	(45,802)
Net cash used in investing activities	(63,296)	(81,424)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock upon exercise of vested options	27,497	48,272
Repurchases of unvested common stock	0	(223)
Proceeds from issuance of common stock under employee stock purchase plan	15,603	17,172
Net cash provided by financing activities	43,100	65,221
Effect of exchange rate changes on cash and cash equivalents	(873)	(103)
Net decrease in cash and cash equivalents	(38,433)	(123,138)
Cash and cash equivalents at beginning of period	349,761	435,781
Cash and cash equivalents at end of period	311,328	312,643
Cash paid for:
Income taxes	5,142	3,979
Non-cash investing and financing activities:
Stock-based compensation capitalized as internal-use software costs	10,102	9,732
Vesting of early exercised stock options	$ 617	$ 1,904

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (89,900)	$ (103,425)	$ (182,867)	$ (255,980)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Insider Trading Arrangements During the three months ended June 30, 2024, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions or written plans for the purchase or sale of the Company’s securities set forth in the table below. Type of Trading Arrangement Name and Position Action Adoption/ Termination Date Rule 10b5-1* Non-Rule 10b5-1** Total Shares of Class A Common Stock to be Sold Expiration Date Stephanie Buscemi - Chief Marketing Officer Termination (1) 6/14/2024 X Up to 854,050 (2) 11/15/2024 Stephanie Buscemi - Chief Marketing Officer Adoption (1) 6/14/2024 X (3) 9/15/2025 Ying Christina Liu - Former Chief Accounting Officer Termination 5/23/2024 X Up to 293,332 3/28/2025 Matthew Miller - Director Termination (4 ) 6/13/2024 X Up to 122,313 6/16/2025 Matthew Miller - Director Adoption (4 ) 6/13/2024 X Up to 219,627 9/15/2025 Michelangelo Volpi - Director Adoption 5/28/2024 X Up to 100,000 8/15/2025 * Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. (1) Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a written plan adopted on August 9, 2023 that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. (2) The shares that may have been sold under the Rule 10b5-1 trading plan included (i) up to 12,029 shares of our Class A Common Stock owned by Ms. Buscemi at the time the plan was adopted, (ii) up to 33,630 shares of our Class A Common Stock subject to restricted stock unit awards previously granted to Ms. Buscemi, which were subject to vesting and release on or prior to November 15, 2024, (iii) up to 807,457 shares of our Class A Common Stock subject to exercisable stock options held by Ms. Buscemi, some of which were subject to vesting on or prior to November 15, 2024, and (iv) up to 934 shares of our Class A Common Stock that Ms. Buscemi purchased under our 2021 Employee Stock Purchase Plan. The actual number of shares that may have been sold under the Rule 10b5-1 trading plan would have been (a) adjusted by the net number of shares available upon vesting of the restricted stock units covered by the plan, after giving effect to the sale of certain such shares to satisfy tax withholding obligations pursuant to Confluent’s non-discretionary sell-to-cover requirement and (b) reduced by any shares sold in accordance with an existing plan prior to its expiration on November 10, 2023. (3) The shares that may be sold under the Rule 10b5-1 trading plan include (i) up to 30,392 shares of our Class A Common Stock currently owned by Ms. Buscemi, (ii) up to 937,692 shares of our Class A Common Stock subject to exercisable stock options held by Ms. Buscemi, 729,316 of which are currently vested and 208,376 of which may vest on or prior to September 15, 2025, (iii) up to 72,005 shares of our Class A Common Stock that are subject to restricted stock unit awards previously granted to Ms. Buscemi that may vest and be released to Ms. Buscemi on or prior to September 15, 2025, and (iv) up to 100% of the shares of our Class A Common Stock that Ms. Buscemi may purchase under our 2021 Employee Stock Purchase Plan on or prior to September 15, 2025, which number of shares is not yet determinable. The actual number of shares that may be sold under the Rule 10b5-1 trading plan will be adjusted by the net number of shares available upon vesting of the restricted stock units covered by the plan, after giving effect to the sale of certain such shares to satisfy tax withholding obligations pursuant to Confluent's non-discretionary sell-to-cover requirement. The actual number of shares that will be subject to the Rule 10b5-1 trading plan is not yet determinable. (4) Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a written plan adopted on March 13, 2024 by a trust affiliated with Matthew Miller that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
Ying Christina Liu [Member]
Trading Arrangements, by Individual
Name	Ying Christina Liu
Title	Former Chief Accounting Officer
Rule 10b5-1 Arrangement Terminated	true
Termination Date	5/23/2024
Expiration Date	3/28/2025
Aggregate Available	293,332
Michelangelo Volpi [Member]
Trading Arrangements, by Individual
Name	Michelangelo Volpi
Title	Director
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	5/28/2024
Expiration Date	8/15/2025
Aggregate Available	100,000
One [Member] | Stephanie Buscemi [Member]
Trading Arrangements, by Individual
Name	Stephanie Buscemi	[1]
Title	Chief Marketing Officer	[1]
Rule 10b5-1 Arrangement Terminated	true	[1]
Termination Date	6/14/2024	[1]
Expiration Date	11/15/2024	[1]
Arrangement Duration	310 days
Aggregate Available	854,050	[1],[2]
One [Member] | Ying Christina Liu [Member]
Trading Arrangements, by Individual
Arrangement Duration	309 days
One [Member] | Matthew Miller [Member]
Trading Arrangements, by Individual
Name	Matthew Miller	[3]
Title	Director	[3]
Rule 10b5-1 Arrangement Terminated	true	[3]
Termination Date	6/13/2024	[3]
Expiration Date	6/16/2025	[3]
Arrangement Duration	368 days
Aggregate Available	122,313	[3]
One [Member] | Michelangelo Volpi [Member]
Trading Arrangements, by Individual
Arrangement Duration	92 days
Two [Member] | Stephanie Buscemi [Member]
Trading Arrangements, by Individual
Name	Stephanie Buscemi	[1]
Title	Chief Marketing Officer	[1]
Rule 10b5-1 Arrangement Adopted	true	[1]
Adoption Date	6/14/2024	[1]
Expiration Date	9/15/2025	[1]
Arrangement Duration	458 days
Two [Member] | Matthew Miller [Member]
Trading Arrangements, by Individual
Name	Matthew Miller	[3]
Title	Director	[3]
Rule 10b5-1 Arrangement Adopted	true	[3]
Adoption Date	6/13/2024	[3]
Expiration Date	9/15/2025	[3]
Arrangement Duration	459 days
Aggregate Available	219,627	[3]
[1] (1) Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a written plan adopted on August 9, 2023 that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. (2) The shares that may have been sold under the Rule 10b5-1 trading plan included (i) up to 12,029 shares of our Class A Common Stock owned by Ms. Buscemi at the time the plan was adopted, (ii) up to 33,630 shares of our Class A Common Stock subject to restricted stock unit awards previously granted to Ms. Buscemi, which were subject to vesting and release on or prior to November 15, 2024, (iii) up to 807,457 shares of our Class A Common Stock subject to exercisable stock options held by Ms. Buscemi, some of which were subject to vesting on or prior to November 15, 2024, and (iv) up to 934 shares of our Class A Common Stock that Ms. Buscemi purchased under our 2021 Employee Stock Purchase Plan. The actual number of shares that may have been sold under the Rule 10b5-1 trading plan would have been (a) adjusted by the net number of shares available upon vesting of the restricted stock units covered by the plan, after giving effect to the sale of certain such shares to satisfy tax withholding obligations pursuant to Confluent’s non-discretionary sell-to-cover requirement and (b) reduced by any shares sold in accordance with an existing plan prior to its expiration on November 10, 2023. (4) Represents the modification, as described in Rule 10b5-1(c)(1)(iv) under the Exchange Act, of a written plan adopted on March 13, 2024 by a trust affiliated with Matthew Miller that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.

Organization and Description of

Organization and Description of Business	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	1. Organization and Description of Business Description of Business Confluent , Inc. (“Confluent” or the “Company”) created a data infrastructure platform focused on data in motion. Confluent’s platform allows customers to connect their applications, systems, and data layers and can be deployed either as a self-managed software offering, Confluent Platform, or as a fully-managed cloud-native software-as-a-service (“SaaS”) offering, Confluent Cloud. Confluent also offers professional services and education services. The Company was incorporated in the state of Delaware in September 2014 and is headquartered in California with various other global office locations.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	2. Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC on February 21, 2024 (the “ Annual Report ” ) . In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2024, the results of operations for the three and six months ended June 30, 2024 and 2023, and cash flows for the six months ended June 30, 2024 and 2023. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, the standalone selling price (“SSP”) for each distinct performance obligation included in customer contracts, deferred contract acquisition costs and their period of benefit, stock-based compensation expense, the fair value of acquired intangible assets, capitalization and estimated useful life of internal-use software, the incremental borrowing rate used to measure operating lease liabilities, and accounting for income taxes. The Company bases its estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances. Estimates and assumptions about future events and their effects, including the impact of global macroeconomic conditions, cannot be determined with certainty and therefore require the exercise of judgment. Actual results could differ from those estimates and any such differences may be material to the Company’s condensed consolidated financial statements. Significant Accounting Policies There were no significant changes to the Company’s significant accounting policies disclosed in “Note 2 – Basis of Presentation and Summary of Significant Accounting Policies” of the Company’s Annual Report. Recent Accounting Pronouncements Recent Accounting Pronouncements Not Yet Adopted Segment Reporting: In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures. Income Taxes: In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. This ASU is effective for fiscal years beginning after December 15, 2024, and may be applied on a retrospective or prospective basis. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

Marketable Securities

Marketable Securities	6 Months Ended
	Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	3. Marketable Securities The following tables summarize the fair values of the Company’s marketable securities (in thousands): June 30, 2024 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 742,758 $ 5 $ ( 1,156 ) $ 741,607 Corporate notes and bonds 452,210 68 ( 1,317 ) 450,961 U.S. agency obligations 346,002 71 ( 758 ) 345,315 Commercial paper 82,010 - ( 40 ) 81,970 Total marketable securities $ 1,622,980 $ 144 $ ( 3,271 ) $ 1,619,853 December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 834,235 $ 257 $ ( 1,355 ) $ 833,137 U.S. agency obligations 403,035 599 ( 875 ) 402,759 Corporate notes and bonds 279,328 838 ( 457 ) 279,709 Commercial paper 35,407 - ( 3 ) 35,404 Total marketable securities $ 1,552,005 $ 1,694 $ ( 2,690 ) $ 1,551,009 The following tables summarize the fair values and unrealized losses of the Company’s marketable securities, classified by the length of time that the securities have been in a continuous unrealized loss position (in thousands): June 30, 2024 Less than 12 Months 12 Months or Greater Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. treasury securities $ 506,864 $ ( 788 ) $ 181,167 $ ( 368 ) $ 688,031 $ ( 1,156 ) Corporate notes and bonds 339,304 ( 1,049 ) 50,707 ( 268 ) 390,011 ( 1,317 ) U.S. agency obligations 209,623 ( 525 ) 95,438 ( 233 ) 305,061 ( 758 ) Commercial paper 18,055 ( 40 ) - - 18,055 ( 40 ) Total $ 1,073,846 $ ( 2,402 ) $ 327,312 $ ( 869 ) $ 1,401,158 $ ( 3,271 ) December 31, 2023 Less than 12 Months 12 Months or Greater Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. treasury securities $ 487,260 $ ( 1,074 ) $ 46,130 $ ( 281 ) $ 533,390 $ ( 1,355 ) U.S. agency obligations 206,105 ( 390 ) 80,657 ( 485 ) 286,762 ( 875 ) Corporate notes and bonds 100,295 ( 293 ) 31,277 ( 164 ) 131,572 ( 457 ) Commercial paper 6,810 ( 3 ) - - 6,810 ( 3 ) Total $ 800,470 $ ( 1,760 ) $ 158,064 $ ( 930 ) $ 958,534 $ ( 2,690 ) For available-for-sale debt securities in an unrealized loss position, the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or a recovery of the cost basis. The Company determined that the decline in fair value of these securities was not due to credit-related factors, and no allowance for expected credit losses was recorded as of June 30, 2024 and December 31, 2023. Realized gains and losses were not material for the three and six months ended June 30, 2024 and 2023. The following table summarizes the contractual maturities of the Company’s marketable securities (in thousands): June 30, 2024 Amortized Cost Fair Value Due within one year $ 1,175,453 $ 1,173,346 Due after one year through five years 447,527 446,507 Total $ 1,622,980 $ 1,619,853

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	4. Fair Value of Financial Instruments The following tables summarize the Company’s financial assets and liabilities that are measured at fair value on a recurring basis (in thousands): June 30, 2024 Level 1 Level 2 Total Assets: Cash equivalents: Money market funds $ 273,038 $ - $ 273,038 Commercial paper - 8,439 8,439 U.S. treasury securities - 1,994 1,994 Marketable securities: U.S. treasury securities - 741,607 741,607 Corporate notes and bonds - 450,961 450,961 U.S. agency obligations - 345,315 345,315 Commercial paper - 81,970 81,970 Derivative instruments: Foreign currency forward contracts - 1,659 1,659 Total assets $ 273,038 $ 1,631,945 $ 1,904,983 Liabilities: Derivative instruments: Foreign currency forward contracts $ - $ 842 $ 842 Total liabilities $ - $ 842 $ 842 December 31, 2023 Level 1 Level 2 Total Assets: Cash equivalents: Money market funds $ 264,923 $ - $ 264,923 U.S. treasury securities - 52,130 52,130 Marketable securities: U.S. treasury securities - 833,137 833,137 U.S. agency obligations - 402,759 402,759 Corporate notes and bonds - 279,709 279,709 Commercial paper - 35,404 35,404 Derivative instruments: Foreign currency forward contracts - 3,219 3,219 Total assets $ 264,923 $ 1,606,358 $ 1,871,281 Liabilities: Derivative instruments: Foreign currency forward contracts $ - $ 1,272 $ 1,272 Total liabilities $ - $ 1,272 $ 1,272 The Company classifies its highly liquid money market funds within Level 1 of the fair value hierarchy because they are valued based on quoted market prices in active markets. The Company classifies its U.S. treasury securities, corporate notes and bonds, U.S. agency obligations, commercial paper, and foreign currency forward contracts within Level 2 of the fair value hierarchy because they are valued using inputs other than quoted prices that are directly or indirectly observable in the market, including readily available pricing sources for the identical underlying security that may not be actively traded. There were no transfers of financial instruments between valuation levels during the three and six months ended June 30, 2024 and 2023. As of June 30, 2024 and December 31, 2023, the total estimated fair value of the Company’ s 0% convertible senior notes due 2027 was $ 949.7 million and $ 917.9 million, respectively. The fair value was determined based on the quoted price of the convertible senior notes in an inactive market on the last trading day of the reporting period and is classified within Level 2 of the fair value hierarchy. See Note 8 for further information on the Company ’ s convertible senior notes.

Derivative Instruments and Hedg

Derivative Instruments and Hedging	6 Months Ended
	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging	5. Derivative Instruments and Hedging The Company enters into foreign currency forward contracts with certain financial institutions to mitigate the impact of foreign currency fluctuations on future cash flows and earnings. Derivative instruments that hedge the exposure to variability in expected future cash flows are designated as cash flow hedges. The Company records changes in the fair value of these derivatives as a component of accumulated other comprehensive income (loss) (“AOCI”) and subsequently reclassifies the related gains or losses into cost of revenue or operating expense in the same period, or periods, during which the hedged transaction affects earnings. The Company classifies cash flows related to its cash flow hedges as operating activities in its condensed consolidated statements of cash flows. Derivative instruments that hedge the exposure to variability in the fair value of assets or liabilities or hedge monetary assets and liabilities denominated in certain non-USD currencies are not designated as hedges for financial reporting purposes. The Company records changes in the fair value of these derivatives in other income (expense), net in the condensed consolidated statements of operations. The Company classifies cash flows related to these derivatives as operating activities in its condensed consolidated statements of cash flows. The following table summarizes the notional amounts of the Company ’s derivative instruments (in thousands): June 30, 2024 December 31, 2023 Foreign currency forward contracts designated as hedging instruments $ 112,867 $ 125,617 Foreign currency forward contracts not designated as hedging instruments 84,359 99,918 Total derivative instruments $ 197,226 $ 225,535 The Company has master netting agreements with each of its counterparties, which permit net settlement of multiple, separate derivative contracts with a single payment. The Company does not have collateral requirements with any of its counterparties. Although the Company is allowed to present the fair value of derivative instruments on a net basis according to master netting arrangements, the Company has elected to present its derivative instruments on a gross basis in its condensed consolidated financial statements. The Company’ s derivative instruments generally have maturities of 18 months or less. The Company does not use derivative instruments for trading or speculative purposes. The following table summarizes the fair value of the Company ’s derivative instruments on the condensed consolidated balance sheets (in thousands): Balance Sheet Location June 30, 2024 December 31, 2023 Derivative Assets: Foreign currency forward contracts designated as hedging instruments Prepaid expenses and other current assets $ 1,109 $ 1,789 Foreign currency forward contracts not designated as hedging instruments Prepaid expenses and other current assets 385 906 Foreign currency forward contracts designated as hedging instruments Other assets, non-current 165 524 Total derivative assets $ 1,659 $ 3,219 Derivative Liabilities: Foreign currency forward contracts designated as hedging instruments Accrued expenses and other liabilities $ 225 $ 18 Foreign currency forward contracts not designated as hedging instruments Accrued expenses and other liabilities 617 1,239 Foreign currency forward contracts designated as hedging instruments Other liabilities, non-current - 15 Total derivative liabilities $ 842 $ 1,272 The following table presents the activity of foreign currency forward contracts designated as hedging instruments and the impact of these derivatives on AOCI (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Beginning balance $ 543 $ 1,024 $ 2,280 $ 653 Net gain (loss) recognized in other comprehensive income (loss) 675 222 ( 937 ) 1,065 Net gain reclassified from AOCI to earnings ( 169 ) ( 706 ) ( 294 ) ( 1,178 ) Ending balance $ 1,049 $ 540 $ 1,049 $ 540 As of June 30, 2024 , net unrealized gains included in the balance of accumulated other comprehensive (loss) income related to foreign currency forward contracts designated as hedging instruments was $ 1.0 million, $ 0.9 million of which the Company expects to reclassify from accumulated other comprehensive (loss) income into earnings over the next 12 months. The following table summarizes the effect of foreign currency forward contracts on the condensed consolidated statements of operations (in thousands): Derivatives Designated as Hedging Instruments Derivatives Not Designated as Hedging Instruments Three Months Ended June 30, Six Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 2024 2023 2024 2023 Cost of revenue - subscription $ 30 $ 89 $ 54 $ 133 $ - $ - $ - $ - Cost of revenue - services 11 60 19 108 - - - - Research and development 33 140 64 199 - - - - Sales and marketing 66 318 99 581 - - - - General and administrative 29 99 58 157 - - - - Other (expense) income, net - - - - ( 242 ) 11 ( 1,049 ) 87 Total gains (losses) recognized in earnings $ 169 $ 706 $ 294 $ 1,178 $ ( 242 ) $ 11 $ ( 1,049 ) $ 87

Balance Sheet Components

Balance Sheet Components	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Balance Sheet Components	6. Balance Sheet Components Property and Equipment, Net The cost and accumulated depreciation and amortization of property and equipment were as follows (in thousands): June 30, 2024 December 31, 2023 Computers, equipment, and software $ 12,482 $ 11,300 Furniture and fixtures 1,039 916 Leasehold improvements 409 380 Capitalized internal-use software costs 66,363 38,999 Construction in progress - capitalized internal-use software costs 20,885 27,831 Property and equipment, at cost $ 101,178 $ 79,426 Less: Accumulated depreciation and amortization ( 34,387 ) ( 25,414 ) Property and equipment, net $ 66,791 $ 54,012 Depreciation and amortization expense was $ 5.3 million and $ 3.2 million for the three months ended June 30, 2024 and 2023, respectively, and $ 9.1 million and $ 6.2 million for the six months ended June 30, 2024 and 2023, respectively. Accrued Expenses and Other Liabilities Accrued expenses and other liabilities consisted of the following (in thousands): June 30, 2024 December 31, 2023 Accrued compensation and benefits $ 55,057 $ 74,497 Accrued income taxes 28,099 2,264 Accrued expenses 18,734 13,471 Accrued commissions 17,599 17,418 Accrued payroll taxes 16,193 9,162 Employee contributions under employee stock purchase plan 12,959 13,946 Other liabilities 18,136 11,089 Total accrued expenses and other liabilities $ 166,777 $ 141,847

Business Combination, Goodwill,

Business Combination, Goodwill, and Intangible Assets	6 Months Ended
	Jun. 30, 2024
Business Combination, Intangible Assets, and Goodwill [ Abstract]
Business Combination, Goodwill, and Intangible Assets	7. Business Combinations, Goodwill, and Intangible Assets Business Combinations In January 2023, the Company acquired all outstanding shares of immerok GmbH (“Immerok”), an Apache Flink stream processing managed services company, for purchase consideration of $ 54.9 million in cash. The Company acquired Immerok primarily for its talent and developed technology. In allocating the purchase consideration, the Company recorded $ 9.1 million of cash acquired, $ 2.6 million as a developed technology intangible asset, to be amortized on a straight-line basis over an estimated useful life of five years , and $ 43.5 million of goodwill. The goodwill is primarily attributed to the assembled workforce and expected synergies arising from the acquisition, and is not deductible for income tax purposes. The Company also entered into holdback agreements with certain employees of Immerok, pursuant to which the Company will pay up to an aggregate of $ 52.3 million in cash. The vesting and payout of the holdback is subject to continued employment and achievement of certain milestones over three years, and is recorded as post-combination compensation expense within operating expenses over the requisite service period for accounting purposes. The Company recognized compensation expense of $ 4.3 million related to the holdback agreements for both the three months ended June 30, 2024 and 2023 , and $ 8.7 million for both the six months ended June 30, 2024 and 2023. In December 2023, the Company acquired certain assets of Noteable, Inc. for purchase consideration of $ 10.0 million in cash. The Company has accounted for this transaction as a business combination. In allocating the purchase consideration, the Company recorded $ 1.5 million as a developed technology intangible asset, to be amortized on a straight-line basis over an estimated useful life of one year , and $ 8.5 million of goodwill, which is deductible for income tax purposes. The purchase price allocation is subject to measurement period adjustments until December 2024. Transaction costs associated with each of the business combinations above were not material during the three and six months ended June 30, 2024 and 2023 and were recorded as general and administrative expenses in the condensed consolidated statements of operations. Goodwill No changes were made to the carrying values of goodwill during the six months ended June 30, 2024. Goodwill as of June 30, 2024 and December 31, 2023 was $ 52.0 million. Intangible Assets, Net Intangible assets, net consisted of the following (in thousands): June 30, 2024 Gross Accumulated Amortization Net Developed technology $ 4,056 $ ( 1,567 ) $ 2,489 Total $ 4,056 $ ( 1,567 ) $ 2,489 December 31, 2023 Gross Accumulated Amortization Net Developed technology $ 4,056 $ ( 564 ) $ 3,492 Total $ 4,056 $ ( 564 ) $ 3,492 Amortization expense was not material for the three and six months ended June 30, 2024 and 2023. As of June 30, 2024, future amortization expense is expected to be as follows (in thousands): Year Ending December 31, Amount Remainder of 2024 $ 944 2025 511 2026 511 2027 511 2028 12 Total $ 2,489

Convertible Senior Notes

Convertible Senior Notes	6 Months Ended
	Jun. 30, 2024
Convertible Debt [Abstract]
Convertible Senior Notes	8. Convertible Senior Notes In December 2021, the Company issued $ 1.1 billion aggregate principal amount of 0 % convertible senior notes due 2027 (the “2027 Notes”), including the exercise in full of the initial purchasers’ option to purchase up to an additional $ 100.0 million principal amount of the 2027 Notes, in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act. The 2027 Notes are general unsecured obligations of the Company and will mature on January 15, 2027, unless earlier converted, redeemed, or repurchased. The 2027 Notes do not bear regular interest, and the principal amount of the 2027 Notes will not accrete. Special interest, if any, is payable semiannually in arrears on January 15 and July 15 of each year, beginning on July 15, 2022 (if and to the extent that special interest is then payable on the 2027 Notes). No special interest has been paid in connection with the 2027 Notes to date. The total net proceeds from the offering, after deducting initial purchasers’ discounts and debt issuance costs, were $ 1,080.5 million. The initial conversion rate is 9.9936 shares of the Company’s Class A common stock per $1,000 principal amount of 2027 Notes (equivalent to an initial conversion price of approximately $ 100.06 per share of the Company’s Class A common stock), subject to adjustment as set forth in the indenture governing the 2027 Notes (the “Indenture”). The 2027 Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding October 15, 2026, only under the following conditions: (1) during any calendar quarter commencing after the calendar quarter ending on March 31, 2022 (and only during such calendar quarter), if the last reported sale price of the Company’s Class A common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130 % of the conversion price for the 2027 Notes on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the “measurement period”) in which the trading price per $ 1,000 principal amount of the 2027 Notes for each trading day of the measurement period was less than 98 % of the product of the last reported sale price of the Company’s Class A common stock and the conversion rate for the 2027 Notes on each such trading day; (3) if the Company calls such 2027 Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date, but only with respect to the 2027 Notes called (or deemed called) for redemption; or (4) upon the occurrence of specified corporate events as set forth in the Indenture. On or after October 15, 2026, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the 2027 Notes may convert all or any portion of their 2027 Notes at any time, at the option of the holder regardless of the foregoing conditions. Upon conversion, the Company may satisfy its conversion obligation by paying or delivering, as the case may be, cash, shares of Class A common stock or a combination of cash and shares of Class A common stock, at the Company’s election, in the manner and subject to the terms and conditions provided in the Indenture. In addition, following certain corporate events that occur prior to the maturity date of the 2027 Notes or if the Company delivers a notice of redemption in respect of the 2027 Notes, the Company will, under certain circumstances, increase the conversion rate of the 2027 Notes for a holder who elects to convert its 2027 Notes in connection with such a corporate event or convert its 2027 Notes called (or deemed called) for redemption in connection with such notice of redemption, as the case may be. During the three months ended June 30, 2024, the conditions allowing holders of the 2027 Notes to convert have not been met. The 2027 Notes were therefore not convertible and were classified as long-term debt on the Company’s condensed consolidated balance sheets as of June 30, 2024 and December 31, 2023. The Company may not redeem the 2027 Notes prior to January 20, 2025. The Company may redeem for cash all or any portion of the 2027 Notes (subject to the certain limitations described in the Indenture), at its option, on or after January 20, 2025, if the last reported sale price of the Company’s Class A common stock has been at least 130 % of the conversion price for the 2027 Notes then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100 % of the principal amount of the 2027 Notes to be redeemed, plus accrued and unpaid special interest, if any, to, but excluding, the redemption date. If the Company redeems less than all of the outstanding 2027 Notes, at least $ 100.0 million aggregate principal amount of 2027 Notes must be outstanding and not subject to redemption as of, and after giving effect to, delivery of the relevant notice of redemption. No sinking fund is provided for the 2027 Notes. The Company incurred $ 19.5 million of debt issuance costs related to the 2027 Notes. These costs are amortized to interest expense included within other income (expense), net on the condensed consolidated statements of operations over the contractual term of the 2027 Notes at an effective interest rate of 0.35 %. Amortization of debt issuance costs was $ 0.9 million and $ 1.0 million for the three months ended June 30, 2024 and 2023 , respectively, and $ 1.9 million for both the six months ended June 30, 2024 and 2023. The net carrying amount of the 2027 Notes was as follows (in thousands): June 30, 2024 December 31, 2023 Principal $ 1,100,000 $ 1,100,000 Unamortized debt issuance costs ( 9,781 ) ( 11,687 ) Net carrying amount $ 1,090,219 $ 1,088,313 Capped Calls In connection with the pricing of the 2027 Notes and the exercise in full by the initial purchasers of their option to purchase additional 2027 Notes, the Company entered into capped call transactions with certain of the initial purchasers of the 2027 Notes or their respective affiliates and other financial institutions (the “Capped Calls”). The Capped Calls each have an initial strike price of approximately $ 100.06 per share, subject to certain adjustments, which corresponds to the initial conversion price of the 2027 Notes. The Capped Calls have initial cap prices of $ 138.02 per share, subject to certain adjustments. The Capped Calls associated with the 2027 Notes cover, subject to anti-dilution adjustments, approximately 11.0 million shares of the Company’s Class A common stock. The Capped Calls are expected generally to reduce the potential dilution to the Company’s Class A common stock upon any conversion of the 2027 Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted 2027 Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. For accounting purposes, the Capped Calls are separate transactions and not part of the terms of the 2027 Notes. As these transactions meet certain accounting criteria, the Capped Calls are recorded in stockholders’ equity and are not accounted for as derivatives. The cost of $ 91.0 million incurred to purchase the Capped Calls was recorded as a reduction to additional paid-in capital and will not be remeasured.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	9. Commitments and Contingencies Leases The Company has entered into non-cancelable operating leases, primarily for the rent of office space expiring at various dates through 2029. Certain lease agreements contain an option for the Company to renew the lease for a term of up to five years or an option to terminate the lease early within three years of lease termination . The Company considers these options in determining the lease term and minimum lease payments on a lease-by-lease basis. None of the Company’s lease agreements contain any material non-lease components, material residual value guarantees, or material restrictive covenants. In 2019, the Company was issued a letter of credit of $ 8.2 million for its office space in Mountain View, California. The letter of credit was reduced to $ 6.5 million during the three months ended June 30, 2024. No draws have been made under the letter of credit as of June 30, 2024 and December 31, 2023. During the six months ended June 30, 2023 , the Company ceased use of certain leased office space. The Company accelerated amortization of the related operating lease right-of-use assets and recognized $ 15.7 million of lease abandonment charges within restructuring and other related charges in the condensed consolidated statements of operations. Purchase Obligations During the six months ended June 30, 2024, there were no material changes to the Company’s purchase obligations from those disclosed in the Company’s Annual Report. Legal Matters From time to time, the Company has become involved in claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise. As of June 30, 2024 and December 31, 2023, the Company is not aware of any matters that would individually or taken together have a material adverse effect on the Company’s results of operations, financial position, or cash flows. Indemnification The Company enters into indemnification provisions under its agreements with other companies in the ordinary course of business, including customers, business partners, landlords, and certain third-party vendors. Under these arrangements, the Company agrees to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party resulting from certain Company activities. The terms of these indemnification agreements are generally perpetual and the maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. As of June 30, 2024 and December 31, 2023, the Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements. The Company maintained commercial general liability insurance and product liability insurance during the three and six months ended June 30, 2024 and 2023 to offset certain of the Company’s potential liabilities under these indemnification provisions. The Company also indemnifies certain of its officers, directors, and certain key employees while they are serving in good faith in their respective capacities. As of June 30, 2024 and December 31, 2023 , the Company has not incurred material costs to defend lawsuits or settle claims related to these indemnification agreements.

Revenue

Revenue	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue	10. Revenue Disaggregation of Revenue The following table sets forth revenue disaggregated by geographic markets based on the location of the customer and by subscription and service categories (dollars in thousands): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Geographic markets: United States $ 143,246 61 % $ 113,910 60 % $ 270,656 60 % $ 217,852 60 % International 91,740 39 % 75,375 40 % 181,567 40 % 145,735 40 % Total revenue $ 234,986 100 % $ 189,285 100 % $ 452,223 100 % $ 363,587 100 % Subscriptions and services: Confluent Platform - License $ 26,958 12 % $ 20,544 11 % $ 46,325 10 % $ 39,532 11 % Confluent Platform - PCS (1) 80,381 34 % 72,366 38 % 161,074 36 % 140,307 39 % Confluent Cloud 117,363 50 % 83,578 44 % 224,205 49 % 157,216 43 % Subscription 224,702 96 % 176,488 93 % 431,604 95 % 337,055 93 % Services 10,284 4 % 12,797 7 % 20,619 5 % 26,532 7 % Total revenue $ 234,986 100 % $ 189,285 100 % $ 452,223 100 % $ 363,587 100 % (1) PCS refers to post-contract customer support, maintenance, and upgrades. Remaining Performance Obligations (“RPO”) RPO represent the amount of contracted future revenue that has not yet been recognized as of the end of each period, including both deferred revenue that has been invoiced and non-cancelable committed amounts that will be invoiced and recognized as revenue in future periods. RPO exclude pay-as-you-go arrangements. As of June 30, 2024, the Company’s RPO was $ 887.8 million , approximately 64 % of which is expected to be recognized as revenue over the next 12 months and the substantial majority of the remainder in the next 13 to 36 months. Actual amounts or timing of revenue recognized may differ due to subsequent contract modifications. Deferred Revenue Deferred revenue, including current and non-current balances as of June 30, 2024 and December 31, 2023 was $ 348.5 million and $ 353.0 million , respectively. For the six months ended June 30, 2024 and 2023 , revenue recognized from deferred revenue at the beginning of the year was $ 239.9 million and $ 199.9 million, respectively. Accounts Receivable, Net The unbilled receivables balance included in accounts receivable, net on the condensed consolidated balance sheets was $ 88.9 million and $ 64.2 million as of June 30, 2024 and December 31, 2023, respectively. The Company’s allowance for expected credit losses was not material as of June 30, 2024 and December 31, 2023. Additions to and write-offs against the allowance for expected credit losses were not material for the three and six months ended June 30, 2024 and 2023. Deferred Contract Acquisition Costs The following table summarizes the activity of deferred contract acquisition costs (in thousands): Six Months Ended June 30, 2024 2023 Beginning balance $ 119,752 $ 104,284 Capitalization of contract acquisition costs 25,028 23,966 Amortization of deferred contract acquisition costs ( 26,096 ) ( 21,537 ) Ending balance $ 118,684 $ 106,713

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Stockholders' Equity	11. Stockholders’ Equity Preferred Stock In connection with its IPO, the Company’s amended and restated certificate of incorporation became effective, which authorized the issuance of 10,000,000 shares of undesignated preferred stock with a par value of $ 0.00001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. Common Stock The Company has two classes of common stock: Class A common stock and Class B common stock. In connection with its IPO, the Company’s amended and restated certificate of incorporation authorized the issuance of 1,000,000,000 shares of Class A common stock and 500,000,000 shares of Class B common stock. The shares of Class A common stock and Class B common stock are identical, except with respect to voting, converting, and transfer rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to ten votes. Class A and Class B common stock have a par value of $ 0.00001 per share and are referred to as common stock throughout the notes to the condensed consolidated financial statements, unless otherwise noted. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Each share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. Any holder’s shares of Class B common stock will convert automatically to Class A common stock, on a one-to-one basis, upon the following: (i) sale or transfer of such share of Class B common stock, except for permitted transfers as described in the amended and restated certificate of incorporation; (ii) the death or incapacity of the Class B common stockholder (or nine months after the date of the death or incapacity if the stockholder is one of the Company’s founders); and (iii) on the final conversion date, defined as the earliest of (a) the date fixed by our board of directors that is no less than 61 days and no more than 180 days following the date on which the outstanding shares of Class B common stock represent less than 10 % of the then outstanding shares of Class A and Class B common stock; (b) the last trading day of the fiscal year following the tenth anniversary of the Company’s IPO; or (c) the date specified by a vote of the holders of a majority of the outstanding shares of Class B common stock, voting as a single class. Common Stock Reserved for Future Issuance The Company has reserved the following shares of common stock for future issuance: June 30, 2024 December 31, 2023 2014 Stock Plan: Options outstanding 26,766,038 31,112,073 Restricted stock units outstanding 620,779 1,042,303 2021 Equity Incentive Plan: Options outstanding 22,500 22,500 Restricted stock units outstanding 20,676,757 22,650,063 Remaining shares available for future issuance 49,558,382 37,289,144 2021 Employee Stock Purchase Plan 10,607,090 8,166,130 Total 108,251,546 100,282,213 Equity Incentive Plans In September 2014, the Company’s board of directors adopted and the Company’s stockholders approved the 2014 Stock Plan (the “2014 Plan”). The 2014 Plan was also amended and restated in March 2021 and June 2021. Under the 2014 Plan, the board of directors may grant stock options and other equity-based awards to eligible employees, directors, and consultants. The 2014 Plan was terminated in June 2021 in connection with the IPO, but continues to govern the terms of outstanding awards that were granted prior to the termination of the 2014 Plan. No further equity awards will be granted under the 2014 Plan. With the establishment of the 2021 Equity Incentive Plan (the “2021 Plan”), upon the expiration, forfeiture, cancellation, or reacquisition of any shares of Class B common stock underlying outstanding stock-based awards granted under the 2014 Plan, an equal number of shares of Class A common stock will become available for grant under the 2021 Plan. Equity-based awards granted under the 2014 Plan and the 2021 Plan generally vest over two to four years. All stock option grants expire ten years from the date of grant. In April 2021, the Company’s board of directors adopted, and in June 2021, the Company’s stockholders approved, the 2021 Plan, which became effective at the time of the execution of the underwriting agreement related to the Company’s IPO. The 2021 Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock awards, restricted stock units (“RSUs”) awards , performance awards, and other forms of awards to employees, directors, and consultants, including employees and consultants of the Company’s affiliates. A total of 25,812,876 shares of the Company’s Class A common stock have been reserved for future issuance under the 2021 Plan in addition to (i) the shares that remained available for grant of future awards under the 2014 Plan at the time the 2021 Plan became effective, (ii) shares underlying outstanding stock awards granted under the 2014 Plan that expire, or are forfeited, cancelled, or reacquired, as described above, and (iii) any automatic increases in the number of shares of Class A common stock reserved for future issuance under this plan. On January 1, 2024, the shares available for grant under the 2021 Plan were automatically increased by 15,575,577 shares pursuant to the 2021 Plan. In April 2021, the Company’s board of directors adopted, and in June 2021, the Company’s stockholders approved, the 2021 Employee Stock Purchase Plan (the “2021 ESPP”), which became effective at the time of the execution of the underwriting agreement related to the Company’s IPO. The 2021 ESPP authorizes the issuance of shares of Class A common stock pursuant to purchase rights granted to employees. A total of 5,162,575 shares of the Company’s Class A common stock have been reserved for future issuance under the 2021 ESPP, in addition to any automatic increases in the number of shares of Class A common stock reserved for future issuance under this plan. On January 1, 2024, the shares available for grant under the 2021 ESPP were automatically increased by 3,115,115 shares pursuant to the 2021 ESPP. Except for the initial offering period, the 2021 ESPP provides for 12-month offering periods generally beginning on February 16 and August 16 of each year, and each offering period consists of two six-month purchase periods. The price at which Class A common stock is purchased under the 2021 ESPP is equal to 85 % of the lesser of (1) the fair market value of the Company’s Class A common stock on the offering date or (2) the fair market value of the Company’s Class A common stock on the purchase date. The 2021 ESPP offers a rollover feature pursuant to which, if the fair market value of a share of Class A common stock on the first trading day of a new purchase period is lower than the fair market value on the offering date, that offering period will terminate and participants will be automatically enrolled in a new 12-month offering period. ESPP rollovers occurred in August 2022 and February 2023, which triggered new 12-month offering periods and resulted in immaterial incremental stock-based compensation expense to be recognized over the remaining requisite service periods. Equity Awards Outstanding The following table summarizes stock equity award activity and activity regarding shares available for grant under the 2014 Plan and the 2021 Plan: Equity Awards Outstanding Shares Available for Grant Outstanding Weighted-Average Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Balance as of January 1, 2024 37,289,144 31,134,573 $ 7.98 6.01 $ 480,766 Increase in authorized shares 15,575,577 - $ - Stock options exercised - ( 3,947,036 ) $ 7.33 Stock options forfeited or expired 398,999 ( 398,999 ) $ 14.39 RSUs granted ( 5,909,438 ) - $ - RSUs forfeited or cancelled 2,204,100 - $ - Balance as of June 30, 2024 49,558,382 26,788,538 $ 7.98 5.48 $ 577,822 Vested as of June 30, 2024 23,664,154 $ 7.42 5.39 $ 523,597 Vested and expected to vest as of June 30, 2024 26,788,538 $ 7.98 5.48 $ 577,822 Aggregate intrinsic value represents the difference between the exercise price of the options to purchase common stock and the estimated fair value of the Company’s common stock. The intrinsic value of options exercised was $ 88.2 million and $ 144.7 million for the six months ended June 30, 2024 and 2023 , respectively. No options were granted during the six months ended June 30, 2024 and 2023. Early Exercised Options All stock option holders have the right to exercise unvested options, which are subject to a repurchase right held by the Company at the original exercise price in the event of voluntary or involuntary termination of employment of the stockholder. As of June 30, 2024 and December 31, 2023, there were 67,525 and 135,013 shares that had been early exercised and were subject to repurchase, respectively. The proceeds related to early exercised options are recorded as liabilities within accrued expenses and other liabilities and other liabilities, non-current on the condensed consolidated balance sheets until the options vest, at which point they are reclassified to equity. The liabilities for early exercised options subject to repurchase were immaterial as of June 30, 2024 and December 31, 2023. Shares issued for early exercised options are included in issued and outstanding shares as they are legally issued and outstanding, but are not deemed outstanding for accounting purposes until the shares vest. RSUs The following table summarizes RSU activity under the 2014 Plan and the 2021 Plan: RSUs Outstanding Number of Shares Weighted-Average Unvested balance as of January 1, 2024 23,692,366 $ 28.44 RSUs granted 5,909,438 $ 31.67 RSUs vested ( 6,100,168 ) $ 28.49 RSUs forfeited or cancelled ( 2,204,100 ) $ 30.43 Unvested balance as of June 30, 2024 21,297,536 $ 29.11 Stock-Based Compensation Expense Total stock-based compensation expense was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Cost of revenue - subscription $ 6,956 $ 6,914 $ 13,199 $ 13,242 Cost of revenue - services 2,223 3,125 4,796 5,902 Research and development 40,770 35,420 79,664 65,435 Sales and marketing 33,823 32,889 66,981 61,376 General and administrative 15,335 13,811 29,789 25,493 Stock-based compensation, net of amounts capitalized $ 99,107 $ 92,159 $ 194,429 $ 171,448 Capitalized stock-based compensation 4,505 5,810 10,102 9,732 Total stock-based compensation $ 103,612 $ 97,969 $ 204,531 $ 181,180 As of June 30, 2024, there was $ 585.0 million of unrecognized stock-based compensation expense, which is expected to be recognized over a weighted-average period of 1.8 years.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes The Company computes its provision for (benefit from) income taxes for interim periods by applying its estimated annual effective tax rate to year-to-date loss or income for includable jurisdictions before income taxes from recurring operations and adjusting for discrete tax items arising in that interim period. The Company’s provision for income taxes was $ 3.4 million and $ 1.7 million for the three months ended June 30, 2024 and 2023, respectively, and $ 5.9 million and $ 3.3 million for the six months ended June 30, 2024 and 2023, respectively, primarily due to foreign, federal, and state income taxes. The Company monitors the realizability of the U.S. and U.K. deferred tax assets taking into account all relevant factors. As of June 30, 2024, the Company continued to maintain a full valuation allowance on its U.S. and U.K. deferred tax assets. The Company will release the valuation allowance when there is sufficient positive evidence to support a conclusion that it is more likely than not the deferred tax assets will be realized. Based on the Company ’ s assessment of the U.K. ’ s current income and anticipated future earnings, there is a reasonable possibility that the Company will have sufficient evidence to release a significant portion of the valuation allowance in the U.K. within the next 12 months. However, the Company’s judgment regarding the U.K.’s future earnings and the exact timing and amount of any U.K. valuation allowance release are subject to change due to many factors, including future market conditions, the ability to successfully execute its business plans, and the amount of stock-based compensation tax deductions available in the future. Release of the U.K. valuation allowance would result in the recognition of net deferred tax assets on the Company’ s consolidated balance sheet and would decrease income tax expense in the period the release is recorded.

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	13. Net Loss Per Share The following table presents the calculation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Class A and Class B Class A and Class B Numerator: Net loss $ ( 89,900 ) $ ( 103,425 ) $ ( 182,867 ) $ ( 255,980 ) Denominator: Weighted-average shares used to compute net loss per share, basic and diluted 319,415,586 297,827,200 316,809,384 294,862,197 Net loss per share, basic and diluted $ ( 0.28 ) $ ( 0.35 ) $ ( 0.58 ) $ ( 0.87 ) The following outstanding potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to the Company’s Class A and Class B common stockholders for the periods presented because the impact of including them would have been anti-dilutive: June 30, 2024 June 30, 2023 Stock options 26,788,538 36,467,274 Unvested early exercised stock options 67,525 284,550 RSUs 21,297,536 25,308,465 ESPP 514,211 1,553,885 Shares issuable upon conversion of the 2027 Notes 10,992,960 10,992,960 Total 59,660,770 74,607,134 The Company calculates the potential dilutive effect of its 2027 Notes under the if-converted method. Under this method, diluted net loss per share is determined by assuming that all of the 2027 Notes were converted into shares of the Company’s Class A common stock at the beginning of the reporting period. In connection with the issuance of the 2027 Notes, the Company entered into Capped Calls, which are not included for purposes of calculating the number of diluted weighted-average shares outstanding, as their effect would have been anti-dilutive. The Capped Calls are expected to partially offset the potential dilution to the Company’s Class A common stock upon any conversion of the 2027 Notes.

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as filed with the SEC on February 21, 2024 (the “ Annual Report ” ) . In management’s opinion, the unaudited condensed consolidated financial statements have been prepared on a basis consistent with the annual consolidated financial statements and reflect all adjustments, which include only normal recurring adjustments, necessary for the fair statement of the Company’s financial position as of June 30, 2024, the results of operations for the three and six months ended June 30, 2024 and 2023, and cash flows for the six months ended June 30, 2024 and 2023. The results of operations for the three and six months ended June 30, 2024 are not necessarily indicative of the results to be expected for the full year or any other future interim or annual period. The condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Such estimates include, but are not limited to, the standalone selling price (“SSP”) for each distinct performance obligation included in customer contracts, deferred contract acquisition costs and their period of benefit, stock-based compensation expense, the fair value of acquired intangible assets, capitalization and estimated useful life of internal-use software, the incremental borrowing rate used to measure operating lease liabilities, and accounting for income taxes. The Company bases its estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances. Estimates and assumptions about future events and their effects, including the impact of global macroeconomic conditions, cannot be determined with certainty and therefore require the exercise of judgment. Actual results could differ from those estimates and any such differences may be material to the Company’s condensed consolidated financial statements.
Significant Accounting Policies	Significant Accounting Policies There were no significant changes to the Company’s significant accounting policies disclosed in “Note 2 – Basis of Presentation and Summary of Significant Accounting Policies” of the Company’s Annual Report.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Recent Accounting Pronouncements Not Yet Adopted Segment Reporting: In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. This ASU is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, and requires retrospective application to all prior periods presented in the financial statements. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures. Income Taxes: In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures , which requires disclosure of disaggregated income taxes paid, prescribes standard categories for the components of the effective tax rate reconciliation, and modifies other income tax-related disclosures. This ASU is effective for fiscal years beginning after December 15, 2024, and may be applied on a retrospective or prospective basis. The Company is currently evaluating the impact of adopting this ASU on its consolidated financial statements and disclosures.

Marketable Securities (Tables)

Marketable Securities (Tables)	6 Months Ended
	Jun. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Fair Value and Amortized Cost of Marketable Securities	The following tables summarize the fair values of the Company’s marketable securities (in thousands): June 30, 2024 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 742,758 $ 5 $ ( 1,156 ) $ 741,607 Corporate notes and bonds 452,210 68 ( 1,317 ) 450,961 U.S. agency obligations 346,002 71 ( 758 ) 345,315 Commercial paper 82,010 - ( 40 ) 81,970 Total marketable securities $ 1,622,980 $ 144 $ ( 3,271 ) $ 1,619,853 December 31, 2023 Amortized Cost Unrealized Gains Unrealized Losses Fair Value U.S. treasury securities $ 834,235 $ 257 $ ( 1,355 ) $ 833,137 U.S. agency obligations 403,035 599 ( 875 ) 402,759 Corporate notes and bonds 279,328 838 ( 457 ) 279,709 Commercial paper 35,407 - ( 3 ) 35,404 Total marketable securities $ 1,552,005 $ 1,694 $ ( 2,690 ) $ 1,551,009
Schedule of Fair Values and Unrealized Losses on Marketable Securities	The following tables summarize the fair values and unrealized losses of the Company’s marketable securities, classified by the length of time that the securities have been in a continuous unrealized loss position (in thousands): June 30, 2024 Less than 12 Months 12 Months or Greater Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. treasury securities $ 506,864 $ ( 788 ) $ 181,167 $ ( 368 ) $ 688,031 $ ( 1,156 ) Corporate notes and bonds 339,304 ( 1,049 ) 50,707 ( 268 ) 390,011 ( 1,317 ) U.S. agency obligations 209,623 ( 525 ) 95,438 ( 233 ) 305,061 ( 758 ) Commercial paper 18,055 ( 40 ) - - 18,055 ( 40 ) Total $ 1,073,846 $ ( 2,402 ) $ 327,312 $ ( 869 ) $ 1,401,158 $ ( 3,271 ) December 31, 2023 Less than 12 Months 12 Months or Greater Total Fair Value Unrealized Losses Fair Value Unrealized Losses Fair Value Unrealized Losses U.S. treasury securities $ 487,260 $ ( 1,074 ) $ 46,130 $ ( 281 ) $ 533,390 $ ( 1,355 ) U.S. agency obligations 206,105 ( 390 ) 80,657 ( 485 ) 286,762 ( 875 ) Corporate notes and bonds 100,295 ( 293 ) 31,277 ( 164 ) 131,572 ( 457 ) Commercial paper 6,810 ( 3 ) - - 6,810 ( 3 ) Total $ 800,470 $ ( 1,760 ) $ 158,064 $ ( 930 ) $ 958,534 $ ( 2,690 )
Schedule of Fair Value and Amortized Cost of Contractual Maturities	The following table summarizes the contractual maturities of the Company’s marketable securities (in thousands): June 30, 2024 Amortized Cost Fair Value Due within one year $ 1,175,453 $ 1,173,346 Due after one year through five years 447,527 446,507 Total $ 1,622,980 $ 1,619,853

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following tables summarize the Company’s financial assets and liabilities that are measured at fair value on a recurring basis (in thousands): June 30, 2024 Level 1 Level 2 Total Assets: Cash equivalents: Money market funds $ 273,038 $ - $ 273,038 Commercial paper - 8,439 8,439 U.S. treasury securities - 1,994 1,994 Marketable securities: U.S. treasury securities - 741,607 741,607 Corporate notes and bonds - 450,961 450,961 U.S. agency obligations - 345,315 345,315 Commercial paper - 81,970 81,970 Derivative instruments: Foreign currency forward contracts - 1,659 1,659 Total assets $ 273,038 $ 1,631,945 $ 1,904,983 Liabilities: Derivative instruments: Foreign currency forward contracts $ - $ 842 $ 842 Total liabilities $ - $ 842 $ 842 December 31, 2023 Level 1 Level 2 Total Assets: Cash equivalents: Money market funds $ 264,923 $ - $ 264,923 U.S. treasury securities - 52,130 52,130 Marketable securities: U.S. treasury securities - 833,137 833,137 U.S. agency obligations - 402,759 402,759 Corporate notes and bonds - 279,709 279,709 Commercial paper - 35,404 35,404 Derivative instruments: Foreign currency forward contracts - 3,219 3,219 Total assets $ 264,923 $ 1,606,358 $ 1,871,281 Liabilities: Derivative instruments: Foreign currency forward contracts $ - $ 1,272 $ 1,272 Total liabilities $ - $ 1,272 $ 1,272

Derivative Instruments and He_2

Derivative Instruments and Hedging (Tables)	6 Months Ended
	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of the Company's Derivative Instruments	The following table summarizes the notional amounts of the Company ’s derivative instruments (in thousands): June 30, 2024 December 31, 2023 Foreign currency forward contracts designated as hedging instruments $ 112,867 $ 125,617 Foreign currency forward contracts not designated as hedging instruments 84,359 99,918 Total derivative instruments $ 197,226 $ 225,535
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The following table summarizes the fair value of the Company ’s derivative instruments on the condensed consolidated balance sheets (in thousands): Balance Sheet Location June 30, 2024 December 31, 2023 Derivative Assets: Foreign currency forward contracts designated as hedging instruments Prepaid expenses and other current assets $ 1,109 $ 1,789 Foreign currency forward contracts not designated as hedging instruments Prepaid expenses and other current assets 385 906 Foreign currency forward contracts designated as hedging instruments Other assets, non-current 165 524 Total derivative assets $ 1,659 $ 3,219 Derivative Liabilities: Foreign currency forward contracts designated as hedging instruments Accrued expenses and other liabilities $ 225 $ 18 Foreign currency forward contracts not designated as hedging instruments Accrued expenses and other liabilities 617 1,239 Foreign currency forward contracts designated as hedging instruments Other liabilities, non-current - 15 Total derivative liabilities $ 842 $ 1,272
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	The following table presents the activity of foreign currency forward contracts designated as hedging instruments and the impact of these derivatives on AOCI (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Beginning balance $ 543 $ 1,024 $ 2,280 $ 653 Net gain (loss) recognized in other comprehensive income (loss) 675 222 ( 937 ) 1,065 Net gain reclassified from AOCI to earnings ( 169 ) ( 706 ) ( 294 ) ( 1,178 ) Ending balance $ 1,049 $ 540 $ 1,049 $ 540
Schedule of foreign currency forward contracts on the condensed consolidated statements of operations	The following table summarizes the effect of foreign currency forward contracts on the condensed consolidated statements of operations (in thousands): Derivatives Designated as Hedging Instruments Derivatives Not Designated as Hedging Instruments Three Months Ended June 30, Six Months Ended June 30, Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 2024 2023 2024 2023 Cost of revenue - subscription $ 30 $ 89 $ 54 $ 133 $ - $ - $ - $ - Cost of revenue - services 11 60 19 108 - - - - Research and development 33 140 64 199 - - - - Sales and marketing 66 318 99 581 - - - - General and administrative 29 99 58 157 - - - - Other (expense) income, net - - - - ( 242 ) 11 ( 1,049 ) 87 Total gains (losses) recognized in earnings $ 169 $ 706 $ 294 $ 1,178 $ ( 242 ) $ 11 $ ( 1,049 ) $ 87

Balance Sheet Components (Table

Balance Sheet Components (Tables)	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Summary of Property and Equipment, Net	The cost and accumulated depreciation and amortization of property and equipment were as follows (in thousands): June 30, 2024 December 31, 2023 Computers, equipment, and software $ 12,482 $ 11,300 Furniture and fixtures 1,039 916 Leasehold improvements 409 380 Capitalized internal-use software costs 66,363 38,999 Construction in progress - capitalized internal-use software costs 20,885 27,831 Property and equipment, at cost $ 101,178 $ 79,426 Less: Accumulated depreciation and amortization ( 34,387 ) ( 25,414 ) Property and equipment, net $ 66,791 $ 54,012
Summary of Accrued Expense and Other Liabilities	Accrued expenses and other liabilities consisted of the following (in thousands): June 30, 2024 December 31, 2023 Accrued compensation and benefits $ 55,057 $ 74,497 Accrued income taxes 28,099 2,264 Accrued expenses 18,734 13,471 Accrued commissions 17,599 17,418 Accrued payroll taxes 16,193 9,162 Employee contributions under employee stock purchase plan 12,959 13,946 Other liabilities 18,136 11,089 Total accrued expenses and other liabilities $ 166,777 $ 141,847

Business Combination, Goodwil_2

Business Combination, Goodwill, and Intangible Assets (Tables)	6 Months Ended
	Jun. 30, 2024
Business Combination, Intangible Assets, and Goodwill [ Abstract]
Schedule of Intangible Assets, Net	Intangible assets, net consisted of the following (in thousands): June 30, 2024 Gross Accumulated Amortization Net Developed technology $ 4,056 $ ( 1,567 ) $ 2,489 Total $ 4,056 $ ( 1,567 ) $ 2,489 December 31, 2023 Gross Accumulated Amortization Net Developed technology $ 4,056 $ ( 564 ) $ 3,492 Total $ 4,056 $ ( 564 ) $ 3,492
Schedule of Expected Future Amortization Expense	As of June 30, 2024, future amortization expense is expected to be as follows (in thousands): Year Ending December 31, Amount Remainder of 2024 $ 944 2025 511 2026 511 2027 511 2028 12 Total $ 2,489

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	6 Months Ended
	Jun. 30, 2024
Convertible Debt [Abstract]
Schedule of Net Carrying Amount of Notes	The net carrying amount of the 2027 Notes was as follows (in thousands): June 30, 2024 December 31, 2023 Principal $ 1,100,000 $ 1,100,000 Unamortized debt issuance costs ( 9,781 ) ( 11,687 ) Net carrying amount $ 1,090,219 $ 1,088,313

Revenue (Tables)

Revenue (Tables)	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Summary of Revenue Disaggregated by Geographic Markets	The following table sets forth revenue disaggregated by geographic markets based on the location of the customer and by subscription and service categories (dollars in thousands): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Geographic markets: United States $ 143,246 61 % $ 113,910 60 % $ 270,656 60 % $ 217,852 60 % International 91,740 39 % 75,375 40 % 181,567 40 % 145,735 40 % Total revenue $ 234,986 100 % $ 189,285 100 % $ 452,223 100 % $ 363,587 100 % Subscriptions and services: Confluent Platform - License $ 26,958 12 % $ 20,544 11 % $ 46,325 10 % $ 39,532 11 % Confluent Platform - PCS (1) 80,381 34 % 72,366 38 % 161,074 36 % 140,307 39 % Confluent Cloud 117,363 50 % 83,578 44 % 224,205 49 % 157,216 43 % Subscription 224,702 96 % 176,488 93 % 431,604 95 % 337,055 93 % Services 10,284 4 % 12,797 7 % 20,619 5 % 26,532 7 % Total revenue $ 234,986 100 % $ 189,285 100 % $ 452,223 100 % $ 363,587 100 % (1) PCS refers to post-contract customer support, maintenance, and upgrades.
Schedule of Activity of Deferred Contract Acquisition Costs	The following table summarizes the activity of deferred contract acquisition costs (in thousands): Six Months Ended June 30, 2024 2023 Beginning balance $ 119,752 $ 104,284 Capitalization of contract acquisition costs 25,028 23,966 Amortization of deferred contract acquisition costs ( 26,096 ) ( 21,537 ) Ending balance $ 118,684 $ 106,713

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2024
Stockholders' Equity Note [Abstract]
Common Stock Reserved for Future Issuance	The Company has reserved the following shares of common stock for future issuance: June 30, 2024 December 31, 2023 2014 Stock Plan: Options outstanding 26,766,038 31,112,073 Restricted stock units outstanding 620,779 1,042,303 2021 Equity Incentive Plan: Options outstanding 22,500 22,500 Restricted stock units outstanding 20,676,757 22,650,063 Remaining shares available for future issuance 49,558,382 37,289,144 2021 Employee Stock Purchase Plan 10,607,090 8,166,130 Total 108,251,546 100,282,213
Summary of Stock Equity Award Activity	The following table summarizes stock equity award activity and activity regarding shares available for grant under the 2014 Plan and the 2021 Plan: Equity Awards Outstanding Shares Available for Grant Outstanding Weighted-Average Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Balance as of January 1, 2024 37,289,144 31,134,573 $ 7.98 6.01 $ 480,766 Increase in authorized shares 15,575,577 - $ - Stock options exercised - ( 3,947,036 ) $ 7.33 Stock options forfeited or expired 398,999 ( 398,999 ) $ 14.39 RSUs granted ( 5,909,438 ) - $ - RSUs forfeited or cancelled 2,204,100 - $ - Balance as of June 30, 2024 49,558,382 26,788,538 $ 7.98 5.48 $ 577,822 Vested as of June 30, 2024 23,664,154 $ 7.42 5.39 $ 523,597 Vested and expected to vest as of June 30, 2024 26,788,538 $ 7.98 5.48 $ 577,822
Schedule of Restricted Stock Unit Activity	The following table summarizes RSU activity under the 2014 Plan and the 2021 Plan: RSUs Outstanding Number of Shares Weighted-Average Unvested balance as of January 1, 2024 23,692,366 $ 28.44 RSUs granted 5,909,438 $ 31.67 RSUs vested ( 6,100,168 ) $ 28.49 RSUs forfeited or cancelled ( 2,204,100 ) $ 30.43 Unvested balance as of June 30, 2024 21,297,536 $ 29.11
Summary of Stock-Based Compensation Expense	Total stock-based compensation expense was as follows (in thousands): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Cost of revenue - subscription $ 6,956 $ 6,914 $ 13,199 $ 13,242 Cost of revenue - services 2,223 3,125 4,796 5,902 Research and development 40,770 35,420 79,664 65,435 Sales and marketing 33,823 32,889 66,981 61,376 General and administrative 15,335 13,811 29,789 25,493 Stock-based compensation, net of amounts capitalized $ 99,107 $ 92,159 $ 194,429 $ 171,448 Capitalized stock-based compensation 4,505 5,810 10,102 9,732 Total stock-based compensation $ 103,612 $ 97,969 $ 204,531 $ 181,180

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Schedule of Calculation of Basic and Diluted Net Loss Per Share Attributable to Class A and Class B Stockholders	The following table presents the calculation of basic and diluted net loss per share (in thousands, except share and per share data): Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Class A and Class B Class A and Class B Numerator: Net loss $ ( 89,900 ) $ ( 103,425 ) $ ( 182,867 ) $ ( 255,980 ) Denominator: Weighted-average shares used to compute net loss per share, basic and diluted 319,415,586 297,827,200 316,809,384 294,862,197 Net loss per share, basic and diluted $ ( 0.28 ) $ ( 0.35 ) $ ( 0.58 ) $ ( 0.87 )
Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share	The following outstanding potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to the Company’s Class A and Class B common stockholders for the periods presented because the impact of including them would have been anti-dilutive: June 30, 2024 June 30, 2023 Stock options 26,788,538 36,467,274 Unvested early exercised stock options 67,525 284,550 RSUs 21,297,536 25,308,465 ESPP 514,211 1,553,885 Shares issuable upon conversion of the 2027 Notes 10,992,960 10,992,960 Total 59,660,770 74,607,134

Marketable Securities - Schedul

Marketable Securities - Schedule of Fair Value and Amortized Cost of Marketable Securities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Marketable Securities [Line Items]
Amortized Cost	$ 1,622,980	$ 1,552,005
Unrealized Gains	144	1,694
Unrealized Losses	(3,271)	(2,690)
Fair Value	1,619,853	1,551,009
U.S. Treasury Securities [Member]
Marketable Securities [Line Items]
Amortized Cost	742,758	834,235
Unrealized Gains	5	257
Unrealized Losses	(1,156)	(1,355)
Fair Value	741,607	833,137
U.S. Agency Obligations [Member]
Marketable Securities [Line Items]
Amortized Cost	346,002	403,035
Unrealized Gains	71	599
Unrealized Losses	(758)	(875)
Fair Value	345,315	402,759
Corporate Notes and Bonds [Member]
Marketable Securities [Line Items]
Amortized Cost	452,210	279,328
Unrealized Gains	68	838
Unrealized Losses	(1,317)	(457)
Fair Value	450,961	279,709
Commercial Paper [Member]
Marketable Securities [Line Items]
Amortized Cost	82,010	35,407
Unrealized Gains	0	0
Unrealized Losses	(40)	(3)
Fair Value	$ 81,970	$ 35,404

Marketable Securities - Sched_2

Marketable Securities - Schedule of Fair Values and Unrealized Losses on Marketable Securities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Marketable Securities [Line Items]
Fair Value, Less than 12 Months	$ 1,073,846	$ 800,470
Fair Value, 12 Months or Greater	327,312	158,064
Fair Value, Total	1,401,158	958,534
Unrealized Losses, Less than 12 Months	(2,402)	(1,760)
Unrealized Losses, 12 Months or Greater	(869)	(930)
Unrealized Losses, Total	(3,271)	(2,690)
U.S. Treasury Securities [Member]
Marketable Securities [Line Items]
Fair Value, Less than 12 Months	506,864	487,260
Fair Value, 12 Months or Greater	181,167	46,130
Fair Value, Total	688,031	533,390
Unrealized Losses, Less than 12 Months	(788)	(1,074)
Unrealized Losses, 12 Months or Greater	(368)	(281)
Unrealized Losses, Total	(1,156)	(1,355)
U.S. Agency Obligations [Member]
Marketable Securities [Line Items]
Fair Value, Less than 12 Months	209,623	206,105
Fair Value, 12 Months or Greater	95,438	80,657
Fair Value, Total	305,061	286,762
Unrealized Losses, Less than 12 Months	(525)	(390)
Unrealized Losses, 12 Months or Greater	(233)	(485)
Unrealized Losses, Total	(758)	(875)
Corporate Notes and Bonds [Member]
Marketable Securities [Line Items]
Fair Value, Less than 12 Months	339,304	100,295
Fair Value, 12 Months or Greater	50,707	31,277
Fair Value, Total	390,011	131,572
Unrealized Losses, Less than 12 Months	(1,049)	(293)
Unrealized Losses, 12 Months or Greater	(268)	(164)
Unrealized Losses, Total	(1,317)	(457)
Commercial Paper [Member]
Marketable Securities [Line Items]
Fair Value, Less than 12 Months	18,055	6,810
Fair Value, 12 Months or Greater	0	0
Fair Value, Total	18,055	6,810
Unrealized Losses, Less than 12 Months	(40)	(3)
Unrealized Losses, 12 Months or Greater	0	0
Unrealized Losses, Total	$ (40)	$ (3)

Marketable Securities - Additio

Marketable Securities - Additional Information (Details) - USD ($)	Jun. 30, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Allowance for credit losses	$ 0	$ 0

Marketable Securities - Sched_3

Marketable Securities - Schedule of Fair Value of Contractual Maturities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Due within one year, amortized cost	$ 1,175,453
Due after one year through five years, amortized cost	447,527
Amortized Cost	1,622,980	$ 1,552,005
Due within one year, fair value	1,173,346
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five	446,507
Fair Value	$ 1,619,853	$ 1,551,009

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Marketable securities:
Fair value, Marketable securities	$ 1,619,853	$ 1,551,009
Derivative instruments:
Fair value, Derivative asset	1,659	3,219
Derivative instruments:
Fair value, Derivative liability	842	1,272
U.S. Treasury Securities [Member]
Marketable securities:
Fair value, Marketable securities	741,607	833,137
Corporate Notes and Bonds [Member]
Marketable securities:
Fair value, Marketable securities	450,961	279,709
Commercial Paper [Member]
Marketable securities:
Fair value, Marketable securities	81,970	35,404
Fair Value, Measurements, Recurring [Member]
Cash equivalents, Marketable securities and Derivative instruments:
Assets, Fair Value	1,904,983	1,871,281
Liability, Fair value	842	1,272
Fair Value, Measurements, Recurring [Member] | U.S. Treasury Securities [Member]
Cash equivalents:
Fair value, Cash equivalents	1,994	52,130
Marketable securities:
Fair value, Marketable securities	741,607	833,137
Fair Value, Measurements, Recurring [Member] | U.S. Agency Obligations [Member]
Marketable securities:
Fair value, Marketable securities	345,315	402,759
Fair Value, Measurements, Recurring [Member] | Corporate Notes and Bonds [Member]
Marketable securities:
Fair value, Marketable securities	450,961	279,709
Fair Value, Measurements, Recurring [Member] | Commercial Paper [Member]
Cash equivalents:
Fair value, Cash equivalents	8,439
Marketable securities:
Fair value, Marketable securities	81,970	35,404
Fair Value, Measurements, Recurring [Member] | Foreign Currency Forward Contracts [Member]
Derivative instruments:
Fair value, Derivative asset	1,659	3,219
Derivative instruments:
Fair value, Derivative liability	842	1,272
Fair Value, Measurements, Recurring [Member] | Money Market Funds [Member]
Cash equivalents:
Fair value, Cash equivalents	273,038	264,923
Fair Value, Measurements, Recurring [Member] | Level 1 [Member]
Cash equivalents, Marketable securities and Derivative instruments:
Assets, Fair Value	273,038	264,923
Liability, Fair value	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | U.S. Treasury Securities [Member]
Cash equivalents:
Fair value, Cash equivalents	0	0
Marketable securities:
Fair value, Marketable securities	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | U.S. Agency Obligations [Member]
Marketable securities:
Fair value, Marketable securities	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Corporate Notes and Bonds [Member]
Marketable securities:
Fair value, Marketable securities	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Commercial Paper [Member]
Cash equivalents:
Fair value, Cash equivalents	0
Marketable securities:
Fair value, Marketable securities	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Foreign Currency Forward Contracts [Member]
Derivative instruments:
Fair value, Derivative asset	0	0
Derivative instruments:
Fair value, Derivative liability	0	0
Fair Value, Measurements, Recurring [Member] | Level 1 [Member] | Money Market Funds [Member]
Cash equivalents:
Fair value, Cash equivalents	273,038	264,923
Fair Value, Measurements, Recurring [Member] | Level 2 [Member]
Cash equivalents, Marketable securities and Derivative instruments:
Assets, Fair Value	1,631,945	1,606,358
Liability, Fair value	842	1,272
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | U.S. Treasury Securities [Member]
Cash equivalents:
Fair value, Cash equivalents	1,994	52,130
Marketable securities:
Fair value, Marketable securities	741,607	833,137
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | U.S. Agency Obligations [Member]
Marketable securities:
Fair value, Marketable securities	345,315	402,759
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Corporate Notes and Bonds [Member]
Marketable securities:
Fair value, Marketable securities	450,961	279,709
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Commercial Paper [Member]
Cash equivalents:
Fair value, Cash equivalents	8,439
Marketable securities:
Fair value, Marketable securities	81,970	35,404
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Foreign Currency Forward Contracts [Member]
Derivative instruments:
Fair value, Derivative asset	1,659	3,219
Derivative instruments:
Fair value, Derivative liability	842	1,272
Fair Value, Measurements, Recurring [Member] | Level 2 [Member] | Money Market Funds [Member]
Cash equivalents:
Fair value, Cash equivalents	$ 0	$ 0

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Additional Information (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Zero Percentage Convertible senior notes due 2027
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total estimated fair value of the 2027 Notes	$ 949.7	$ 917.9

Derivative Instruments and He_3

Derivative Instruments and Hedging - Additional Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022
Derivatives, Fair Value [Line Items]
Description of Derivative Instruments	18 months
Foreign currency forward contracts designated as hedging instruments	$ 1,049	$ 543	$ 2,280	$ 540	$ 1,024	$ 653
Foreign Currency Forward Contracts [Member]
Derivatives, Fair Value [Line Items]
Foreign currency forward contracts designated as hedging instruments	1,000
Accumulated other comprehensive (loss) income [Member] | Foreign Currency Forward Contracts [Member]
Derivatives, Fair Value [Line Items]
Derivative instruments, gain (loss) reclassification from accumulated OCI to income, estimated net amount to be transferred	$ 900

Derivative Instruments and He_4

Derivative Instruments and Hedging - Schedule of Notional Amounts of the Company's Derivative Instruments (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Total derivative instruments	$ 197,226	$ 225,535
Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Total derivative instruments	112,867	125,617
Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Total derivative instruments	$ 84,359	$ 99,918

Derivative Instruments and He_5

Derivative Instruments and Hedging - Fair Value of Derivative Instruments on the Balance Sheet (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Derivative Instruments, Gain (Loss) [Line Items]
Derivative assets	$ 1,659	$ 3,219
Derivative liabilities	$ 842	$ 1,272
Foreign Exchange Forward [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Prepaid Expense and Other Assets, Current	Prepaid Expense and Other Assets, Current
Derivative assets	$ 385	$ 906
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities and Other Liabilities	Accrued Liabilities and Other Liabilities
Derivative liabilities	$ 617	$ 1,239
Other Noncurrent Assets | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Derivative assets	$ 165	$ 524
Other Noncurrent Liabilities | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Derivative liabilities	$ 0	$ 15
Prepaid expenses and other current assets | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Prepaid Expense and Other Assets, Current	Prepaid Expense and Other Assets, Current
Derivative assets	$ 1,109	$ 1,789
Accrued expenses and other liabilities | Foreign Exchange Forward [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities and Other Liabilities	Accrued Liabilities and Other Liabilities
Derivative liabilities	$ 225	$ 18

Derivative Instruments and He_6

Derivative Instruments and Hedging - Impact of Derivative Contracts on Accumulated Other Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Beginning Balance	$ 543	$ 1,024	$ 2,280	$ 653
Net gain (loss) recognized in other comprehensive income (loss)	675	222	(937)	1,065
Net gain reclassified from AOCI to earnings	(169)	(706)	(294)	(1,178)
Ending Balance	$ 1,049	$ 540	$ 1,049	$ 540

Derivative Instruments and He_7

Derivative Instruments and Hedging - Summary of Recognized Net Gains (Losses) From Foreign Currency Forward Contracts (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Total gains (losses) recognized in earnings from foreign currency forward contracts	$ (169)	$ (706)	$ (294)	$ (1,178)
Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	169	706	294	1,178
Not Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	(242)	11	(1,049)	87
Cost of revenue - Subscription [Member] | Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	30	89	54	133
Cost of revenue - Subscription [Member] | Not Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	0	0	0	0
Cost of revenue - Services [Member] | Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	11	60	19	108
Cost of revenue - Services [Member] | Not Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	0	0	0	0
Research and Development [Member] | Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	33	140	64	199
Research and Development [Member] | Not Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	0	0	0	0
Sales and Marketing [Member] | Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	66	318	99	581
Sales and Marketing [Member] | Not Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	0	0	0	0
General and Administrative [Member] | Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	29	99	58	157
General and Administrative [Member] | Not Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	0	0	0	0
Other (Expense) Income, Net [Member] | Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	0	0	0	0
Other (Expense) Income, Net [Member] | Not Designated as Hedging Instrument [Member]
Total gains (losses) recognized in earnings from foreign currency forward contracts	$ (242)	$ 11	$ (1,049)	$ 87

Balance Sheet Components - Summ

Balance Sheet Components - Summary of Property and Equipment, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 101,178	$ 79,426
Less: Accumulated depreciation and amortization	(34,387)	(25,414)
Property and equipment, net	66,791	54,012
Computers, Equipment, and Software [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	12,482	11,300
Furniture and Fixtures [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	1,039	916
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	409	380
Capitalized Internal-Use Software Costs [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	66,363	38,999
Construction in Progress Capitalized Internal Use Software Costs [Member]
Property Plant And Equipment [Line Items]
Property and equipment, gross	$ 20,885	$ 27,831

Balance Sheet Components - Addi

Balance Sheet Components - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Property, Plant and Equipment [Abstract]
Depreciation	$ 5.3	$ 3.2	$ 9.1	$ 6.2

Balance Sheet Components - Su_2

Balance Sheet Components - Summary of Accrued Expense and Other Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Accrued compensation and benefits	$ 55,057	$ 74,497
Accrued income taxes	28,099	2,264
Accrued expenses	18,734	13,471
Accrued commissions	17,599	17,418
Accrued payroll taxes	16,193	9,162
Employee contributions under employee stock purchase plan	12,959	13,946
Other liabilities	18,136	11,089
Total accrued expenses and other liabilities	$ 166,777	$ 141,847

Business Combination, Goodwil_3

Business Combination, Goodwill, and Intangible Assets - Additional Information (Details) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 09, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Business Acquisition [Line Items]
Business acquisition, expense attributable to post-combination services		$ 4,300,000	$ 4,300,000	$ 8,700,000	$ 8,700,000
Changes in carrying values of goodwill				0
Goodwill		$ 52,000,000		$ 52,000,000		$ 52,000,000
Immerok Gmbh
Business Acquisition [Line Items]
Purchase Consideration Amount	$ 54,900,000
Cash Acquired	9,100,000
Developed technology intangible asset	$ 2,600,000
Estimated useful life (in years)	5 years
Goodwill	$ 43,500,000
Holdback Agreement
Business Acquisition [Line Items]
Amout paid in cash	$ 52,300,000
Noteable Inc.
Business Acquisition [Line Items]
Cash Acquired						10,000,000
Developed technology intangible asset						$ 1,500,000
Estimated useful life (in years)						1 year
Goodwill						$ 8,500,000

Business Combination, Goodwil_4

Business Combination, Goodwill, and Intangible Assets - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Business Acquisition [Line Items]
Gross	$ 4,056	$ 4,056
Accumulated Amortization	(1,567)	(564)
Net	2,489	3,492
Developed Technology [Member]
Business Acquisition [Line Items]
Gross	4,056	4,056
Accumulated Amortization	(1,567)	(564)
Net	$ 2,489	$ 3,492

Business Combination, Goodwil_5

Business Combination, Goodwill, and Intangible Assets - Schedule of Expected Future Amortization Expense (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Business Combination, Intangible Assets, and Goodwill [ Abstract]
Remainder of 2024	$ 944
2025	511
2026	511
2027	511
2028	12
Total	$ 2,489	$ 3,492

Convertible Senior Notes - Addi

Convertible Senior Notes - Additional Information (Details) $ / shares in Units, $ in Thousands, shares in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024 USD ($) $ / shares	Jun. 30, 2023 USD ($)	Jun. 30, 2024 USD ($) Days $ / shares shares	Jun. 30, 2023 USD ($)
Debt Instrument [Line Items]
Amortization of debt issuance costs	$ 900	$ 1,000	$ 1,906	$ 1,889
Zero Percentage Convertible senior notes due 2027
Debt Instrument [Line Items]
Debt Instrument Face Amount	1,100,000		1,100,000
Debt Instrument Convertible Conversion Ratio Denominator	$ 1,000		$ 1,000
Debt Instrument, Interest Rate, Stated Percentage	0%		0%
Debt instrument net proceed after discounts and cost			$ 1,080,500
Number of trading days | Days			30
Percentage of principal amount of debt redeemed			100%
Debt Issuance Costs, Gross	$ 19,500		$ 19,500
Effective interest rate of debt	0.35%		0.35%
Debt instrument percentage price			130%
Zero Percentage Convertible senior notes due 2027 | Common Stock Subject to Mandatory Redemption [Member]
Debt Instrument [Line Items]
Debt Instrument Face Amount	$ 100,000		$ 100,000
Zero Percentage Convertible senior notes due 2027 | Common Class A [Member]
Debt Instrument [Line Items]
Convertible debt, conversion ratio			9.9936
Debt Instrument, Convertible, Conversion Price | $ / shares	$ 100.06		$ 100.06
Debt instrument percentage price			130%
Zero Percentage Convertible senior notes due 2027 | Maximum [Member]
Debt Instrument [Line Items]
Debt Instrument Face Amount	$ 100,000		$ 100,000
Debt instrument percentage price	98%		98%
Zero Percentage Convertible senior notes due 2027 | Minimum [Member]
Debt Instrument [Line Items]
Number of trading days | Days			20
Zero Percentage Convertible senior notes due 2027 | Capped Calls [Member]
Debt Instrument [Line Items]
Initial strike price | $ / shares			$ 100.06
Initial cap price | $ / shares	$ 138.02		$ 138.02
Payments for purchase of capped calls	$ 91,000		$ 91,000
Zero Percentage Convertible senior notes due 2027 | Capped Calls [Member] | Common Class A [Member]
Debt Instrument [Line Items]
Adjustment to anti-dilution common stock | shares			11

Convertible Senior Notes - Sche

Convertible Senior Notes - Schedule of Net Carrying Amount of Notes (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Convertible Debt [Abstract]
Principal	$ 1,100,000	$ 1,100,000
Unamortized debt issuance costs	(9,781)	(11,687)
Net carrying amount	$ 1,090,219	$ 1,088,313

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2019
Lessee Lease Description [Line Items]
Operating lease, option to terminate, description	an option to terminate the lease early within three years of lease termination
Lease abandonment charges	$ 0	$ 15,667
CALIFORNIA [Member]
Lessee Lease Description [Line Items]
Letters of credit outstanding amount	$ 6,500		$ 8,200
Maximum [Member]
Lessee Lease Description [Line Items]
Lessee, operating lease, renewal term	5 years

Revenue - Summary of Revenue Di

Revenue - Summary of Revenue Disaggregated by Geographic Markets (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation Of Revenue [Line Items]
Total revenue		$ 234,986	$ 189,285	$ 452,223	$ 363,587
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | Major Customers [Member]
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		100%	100%	100%	100%
Revenue Benchmark [Member] | Subscription and Service Concentration Risk [Member] | Major Customers [Member]
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		100%	100%	100%	100%
United States [Member]
Disaggregation Of Revenue [Line Items]
Total revenue		$ 143,246	$ 113,910	$ 270,656	$ 217,852
United States [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		61%	60%	60%	60%
International [Member]
Disaggregation Of Revenue [Line Items]
Total revenue		$ 91,740	$ 75,375	$ 181,567	$ 145,735
International [Member] | Revenue Benchmark [Member] | Geographic Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		39%	40%	40%	40%
License [Member]
Disaggregation Of Revenue [Line Items]
Total revenue		$ 26,958	$ 20,544	$ 46,325	$ 39,532
License [Member] | Revenue Benchmark [Member] | Subscription and Service Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		12%	11%	10%	11%
Post Contract Customer Support [Member]
Disaggregation Of Revenue [Line Items]
Total revenue	[1]	$ 80,381	$ 72,366	$ 161,074	$ 140,307
Post Contract Customer Support [Member] | Revenue Benchmark [Member] | Subscription and Service Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Percentage of Revenue	[1]	34%	38%	36%	39%
Confluent Cloud [Member]
Disaggregation Of Revenue [Line Items]
Total revenue		$ 117,363	$ 83,578	$ 224,205	$ 157,216
Confluent Cloud [Member] | Revenue Benchmark [Member] | Subscription and Service Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		50%	44%	49%	43%
Subscription [Member]
Disaggregation Of Revenue [Line Items]
Total revenue		$ 224,702	$ 176,488	$ 431,604	$ 337,055
Subscription [Member] | Revenue Benchmark [Member] | Subscription and Service Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		96%	93%	95%	93%
Services [Member]
Disaggregation Of Revenue [Line Items]
Total revenue		$ 10,284	$ 12,797	$ 20,619	$ 26,532
Services [Member] | Revenue Benchmark [Member] | Subscription and Service Concentration Risk [Member]
Disaggregation Of Revenue [Line Items]
Percentage of Revenue		4%	7%	5%	7%
[1] PCS refers to post-contract customer support, maintenance, and upgrades.

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Disaggregation Of Revenue [Line Items]
Revenue, remaining performance obligation, amount	$ 887.8
Revenue, remaining performance obligation, percentage	64%
Deferred revenue	$ 348.5		$ 353
Unbilled receivables balance	88.9		$ 64.2
Revenue recognized from deferred revenue	$ 239.9	$ 199.9
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01
Disaggregation Of Revenue [Line Items]
Performance obligations period	12 months
Minimum [Member] | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01
Disaggregation Of Revenue [Line Items]
Performance obligations period	13 months
Maximum [Member] | Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01
Disaggregation Of Revenue [Line Items]
Performance obligations period	36 months

Revenue - Schedule of Activity

Revenue - Schedule of Activity of Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Beginning balance	$ 119,752	$ 104,284
Capitalization of contract acquisition costs	25,028	23,966
Amortization of deferred contract acquisition costs	(26,096)	(21,537)
Ending balance	$ 118,684	$ 106,713

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) $ / shares in Units, $ in Millions		6 Months Ended
	Jan. 01, 2024 shares	Jun. 30, 2024 USD ($) Vote $ / shares shares	Jun. 30, 2023 USD ($) $ / shares	Dec. 31, 2023 $ / shares shares
Class Of Stock [Line Items]
Preferred Stock, Shares Authorized		10,000,000		10,000,000
Preferred Stock, Par or Stated Value Per Share | $ / shares		$ 0.00001		$ 0.00001
Conversion, percent threshold		10%
Common stock reserved for issuance (in shares)		108,251,546		100,282,213
Shares Available for Grant, Increase in authorized shares		15,575,577
Intrinsic value of options exercised | $		$ 88.2	$ 144.7
Weighted average grant date fair value per share of options granted | $ / shares		$ 0	$ 0
Shares early exercised and repurchase		67,525		135,013
Unrecognized stock-based compensation expense | $		$ 585
Unrecognized stock-based compensation expense, weighted-average period		1 year 9 months 18 days
Common Class A [Member]
Class Of Stock [Line Items]
Common Stock, Shares Authorized		1,000,000,000		1,000,000,000
Common stock, voting rights, votes per share | Vote		1
Common Stock, Par Value | $ / shares		$ 0.00001		$ 0.00001
Common Class B [Member]
Class Of Stock [Line Items]
Common Stock, Shares Authorized		500,000,000		500,000,000
Common stock, voting rights, votes per share | Vote		10
Common Stock, Par Value | $ / shares		$ 0.00001		$ 0.00001
2021 Plan [Member]
Class Of Stock [Line Items]
Shares Available for Grant, Increase in authorized shares	15,575,577
2021 Plan [Member] | Common Class A [Member]
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)		25,812,876
2021 Employee Stock Purchase Plan [Member]
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)		10,607,090		8,166,130
Shares Available for Grant, Increase in authorized shares	3,115,115
2021 Employee Stock Purchase Plan [Member] | Common Class A [Member]
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)		5,162,575
Purchase price of common stock expressed as a percentage of its fair value		85%

Stockholders' Equity - Common S

Stockholders' Equity - Common Stock Reserved for Future Issuance (Details) - shares	Jun. 30, 2024	Dec. 31, 2023
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)	108,251,546	100,282,213
2014 Stock Plan [Member] | Employee Stock Option
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)	26,766,038	31,112,073
2014 Stock Plan [Member] | RSUs [Member]
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)	620,779	1,042,303
2021 Equity Incentive Plan [Member]
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)	49,558,382	37,289,144
2021 Equity Incentive Plan [Member] | Employee Stock Option
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)	22,500	22,500
2021 Equity Incentive Plan [Member] | RSUs [Member]
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)	20,676,757	22,650,063
2021 Employee Stock Purchase Plan [Member]
Class Of Stock [Line Items]
Common stock reserved for issuance (in shares)	10,607,090	8,166,130

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Stock Equity Award Activity (Details) $ / shares in Units, $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2024 USD ($) $ / shares shares	Dec. 31, 2023 USD ($) $ / shares shares
Share-Based Payment Arrangement [Abstract]
Shares Available for Grant, Beginning Balance	37,289,144
Shares Available for Grant, Increase in authorized shares	15,575,577
Shares Available for Grant, Stock options forfeited or expired	398,999
Shares Available for Grant, RSUs granted	(5,909,438)
Shares Available for Grant, RSUs Forfeited or Cancelled	2,204,100
Shares Available for Grant, Ending Balance	49,558,382	37,289,144
Outstanding Stock Options, Beginning Balance	31,134,573
Outstanding Stock Options, Stock options exercised	(3,947,036)
Outstanding Stock Options, Stock options forfeited or expired	(398,999)
Outstanding Stock Options, Ending Balance	26,788,538	31,134,573
Outstanding Stock Options, Vested	23,664,154
Outstanding Stock Options, Vested and expected to vest	26,788,538
Weighted-Average Exercise Price, Beginning Balance | $ / shares	$ 7.98
Weighted-Average Exercise Price, Stock options exercised | $ / shares	7.33
Weighted-Average Exercise Price, Stock options forfeited or expired | $ / shares	14.39
Weighted-Average Exercise Price, Ending Balance | $ / shares	7.98	$ 7.98
Weighted-Average Exercise Price, Vested | $ / shares	7.42
Weighted-Average Exercise Price, Vested and Expected to Vest | $ / shares	$ 7.98
Weighted-Average Remaining Contractual Term (in years)	5 years 5 months 23 days	6 years 3 days
Weighted-Average Remaining Contractual Term Vested (in years)	5 years 4 months 20 days
Weighted-Average Remaining Contractual Term Vested and expected to vest (in years)	5 years 5 months 23 days
Aggregate Intrinsic Value, Beginning Balance | $	$ 480,766
Aggregate Intrinsic Value, Ending Balance | $	577,822	$ 480,766
Aggregate Intrinsic Value, Vested as of March 31, 2024 | $	523,597
Aggregate Intrinsic Value, Vested and expected to vest as of March 31, 2024 | $	$ 577,822

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs) [Member]	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]
Number of Shares, Beginning Balance | shares	23,692,366
Number of Shares, RSUs granted | shares	5,909,438
Number of Shares, RSUs vested | shares	(6,100,168)
Number of Shares, RSUs forfeited or cancelled | shares	(2,204,100)
Number of Shares, Ending Balance | shares	21,297,536
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-average grant date fair value, Beginning Balance (in dollars per share) | $ / shares	$ 28.44
Weighted-average grant date fair value, RSUs granted (in dollars per share) | $ / shares	31.67
Weighted-average grant date fair value, RSUs vested (in dollars per share) | $ / shares	28.49
Weighted-average grant date fair value, RSUs forfeited or cancelled (in dollars per share) | $ / shares	30.43
Weighted-average grant date fair value, Ending Balance (in dollars per share) | $ / shares	$ 29.11

Stockholders' Equity - Summar_2

Stockholders' Equity - Summary of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation, net of amounts capitalized	$ 99,107	$ 92,159	$ 194,429	$ 171,448
Capitalized stock-based compensation	4,505	5,810	10,102	9,732
Total stock-based compensation	103,612	97,969	204,531	181,180
Cost of Revenue [Member] | Subscription [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation, net of amounts capitalized	6,956	6,914	13,199	13,242
Cost of Revenue [Member] | Services [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation, net of amounts capitalized	2,223	3,125	4,796	5,902
Research and Development [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation, net of amounts capitalized	40,770	35,420	79,664	65,435
Sales and Marketing [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation, net of amounts capitalized	33,823	32,889	66,981	61,376
General and Administrative [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation, net of amounts capitalized	$ 15,335	$ 13,811	$ 29,789	$ 25,493

Income Taxes - Additional Infor

Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 3,404	$ 1,667	$ 5,870	$ 3,314

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss Per Share Attributable to Stockholders (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Numerator:
Net Income (Loss)	$ (89,900)	$ (103,425)	$ (182,867)	$ (255,980)
Denominator:
Weighted-average shares used to compute net loss per share, basic	319,415,586	297,827,200	316,809,384	294,862,197
Weighted-average shares used to compute net loss per share, diluted	319,415,586	297,827,200	316,809,384	294,862,197
Net loss per share, basic	$ (0.28)	$ (0.35)	$ (0.58)	$ (0.87)
Net loss per share, diluted	$ (0.28)	$ (0.35)	$ (0.58)	$ (0.87)
Class A and Class B [Member]
Numerator:
Net Income (Loss)	$ (89,900)	$ (103,425)	$ (182,867)	$ (255,980)
Denominator:
Weighted-average shares used to compute net loss per share, basic	319,415,586	297,827,200	316,809,384	294,862,197
Weighted-average shares used to compute net loss per share, diluted	319,415,586	297,827,200	316,809,384	294,862,197
Net loss per share, basic	$ (0.28)	$ (0.35)	$ (0.58)	$ (0.87)
Net loss per share, diluted	$ (0.28)	$ (0.35)	$ (0.58)	$ (0.87)

Net Loss Per Share - Schedule_2

Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share amount	59,660,770	74,607,134
Stock Options [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share amount	26,788,538	36,467,274
Unvested Early Exercised Stock Options [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share amount	67,525	284,550
RSUs [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share amount	21,297,536	25,308,465
ESPP [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share amount	514,211	1,553,885
Shares Issuable upon Conversion of the 2027 Notes [Member]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share amount	10,992,960	10,992,960